🔗 Permalink

Assignee profile:

IDAC Theranostics, Inc.

City:

Tokyo

Country:

Japan

Published Applications:

Last publication date:

2019-10-17

Patent Grants:

Last grant date:

2020-07-14

Top Inventors for applications by IDAC Theranostics, Inc.

These are the the leading inventors for applications assigned to IDAC Theranostics, Inc.:

Shoji YOKOCHI 5 Tokyo, Japan
Kouji Matsushima 5 Tokyo, Japan
Satoru ITO 5 Tokyo, Japan
Yoshiro ISHIWATA 4 Tokyo, Japan

Satoshi UEHA 4 Tokyo, Japan
Shin-ichi HASHIMOTO 1 Kanazawa-shi, Japan
Taro YAMASHITA 1 Kanazawa-shi, Japan
Taketo YAMADA 1 Saitama, Japan

Hiroshi YANAGAWA 1 Tokyo, Japan
Shin-ichi Hashimoto 1 Kanazawa, Japan
Shin-ichi Hashimoto 1 Ishikawa, Japan
Yuko YONEMURA 1 Tokyo, Japan

Shuichi KANEKO 1 Kanazawa-shi, Japan
Yoko OGAWA 1 Tokyo, Japan
Takayoshi SHIRASAKI 1 Kanazawa-shi, Japan
Taro Yamashita 1 Kanazawa, Japan

Shuichi Kaneko 1 Kanazawa, Japan
Shuichi KANEKO 1 Ishikawa, Japan
Maiko MATSUSHITA 1 Tokyo, Japan
Yutaka HATTORI 1 Tokyo, Japan

Daiju ICHIKAWA 1 Tokyo, Japan
Masao Honda 1 Kanazawa, Japan
Shuji AIDA 1 Tokyo, Japan
Noriko TABATA 1 Tokyo, Japan

Takayoshi Shirasaki 1 Kanazawa, Japan
Masao HONDA 1 Kanazawa-shi, Japan
Takeshi SUGAI 1 Tokyo, Japan

Recent patent applications by IDAC Theranostics, Inc.

IDAC Theranostics, Inc. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2019-10-17

US20190315775A1

Chemistry; metallurgy

MODIFIED PHENYLPHTHALIMIDE AND PHARMACEUTICAL COMPOSITION HAVING SAME AS ACTIVE INGREDIENT

#2 | 2019-05-02

US20190125867A1

Human necessities

THERAPEUTIC AGENT FOR SOLID CANCER

#3 | 2019-01-24 ✅ Patent 10,709,727 granted on 2020-07-14

US20190022126A1

Human necessities

Antiviral drugs

#4 | 2017-11-16 ✅ Patent 10,746,726 granted on 2020-08-18

US20170328887A1

Physics

Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient

#5 | 2017-06-15 ✅ Patent 10,738,352 granted on 2020-08-11

US20170166959A1

Chemistry; metallurgy

Method for analyzing nucleic acid derived from single cell

#6 | 2017-06-15

US20170165364A1

Human necessities

THERAPEUTIC AGENT FOR SOLID CANCER

#7 | 2017-05-25 ✅ Patent 11,168,137 granted on 2021-11-09

US20170145099A1

Chemistry; metallurgy

Method for reducing side effects of immune checkpoint control agent

#8 | 2016-04-21

US20160108122A1

Chemistry; metallurgy

THERAPEUTIC OR PROPHYLACTIC AGENT FOR IMMUNODEFICIENCY VIRUS INFECTION

Also check out IDAC THERANOSTICS, INC.'s (Tokyo, Japan) applicant profile with 4 patent applications submitted.

AssigneeID:

107318 ⎘